For the Inventor, By the Inventor

Enter assignee name

Alameda, CA, United States of America

Avigen, Inc.

Calculating rank

USPTO Granted Patents = 31

% Expired Patents = 6.5

CIPO Patents = 3

EPO Patents = 4

Forward Citations = 1,070

Loading Chart...

Loading Chart...

30 inventors (with patents filed for the assignee):

Peter C Colosi (14 out of 21 patents)

Gary J Kurtzman (12 out of 20 patents)

Gregory M Podsakoff (5 out of 12 patents)

4. Georges Natsoulis (4 out of 5 patents)

5. Paul D Kessler (3 out of 10 patents)

6. Barry J Byrne (3 out of 8 patents)

7. Kirk William Johnson (3 out of 36 patents)

8. Hideho Okada (2 out of 13 patents)

9. Federico C A Gaeta (2 out of 24 patents)

10. Hema S Sista (2 out of 5 patents)

11. Yero J Espinoza (2 out of 5 patents)

12. Matthew I Gross (2 out of 3 patents)

13. Xiaobing Qian (2 out of 3 patents)

14. Jun Yoshida (2 out of 3 patents)

15. Linda B Couto (2 out of 2 patents)

Core Competencies:

Gene Therapy

Adeno-Associated Virus

Recombinant AAV

CNS Disorders

Neuropathic Pain

Solid Tumors

Pharmaceutical Formulations

Nucleotide Sequence Delivery

Immune Response Induction

Factor VIII Expression

High-Efficiency AAV

Virion Production

31 patents: Sort by Forward Citations

1. 7622256 - Method for selecting compounds that modulate MIF-induced expression of ICAM-1 and/or VCAM-1 (2009-11-24),

2. 7585875 - Substituted pyrazolo[1,5-a]pyridine compounds and their methods of use (2009-09-08),

3. 7534806 - Method for treating neuropathic pain and associated syndromes (2009-05-19),

4. 7037713 - High-efficiency wild-type-free AAV helper functions (2006-05-02),

5. 6953575 - Methods of treating central nervous system disorders using viral vectors (2005-10-11),

6. 6897063 - Accessory functions for use in recombinant AAV virion production (2005-05-24),

7. 6764845 - Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith (2004-07-20),

8. 6759050 - Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith (2004-07-06),

9. 6593123 - Large-scale recombinant adeno-associated virus (rAAV) production and purification (2003-07-15),

10. 6531456 - Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors (2003-03-11),

11. 6482633 - Accessory functions for use in recombinant AAV virion production (2002-11-19),

12. 6416992 - Compositions and methods for producing recombinant adeno-associated virus (2002-07-09),

13. 6391858 - Methods for delivering DNA to the bloodstream using recombinant adeno-associated virus vectors (2002-05-21),

14. 6376237 - High-efficiency wild-type-free AAV helper functions (2002-04-23),

15. 6365403 - High-efficiency AAV helper functions (2002-04-02),

Company Overview

Avigen, Inc. is a biotechnology company based in Alameda, California, specializing in the development of innovative gene therapies. The company focuses on advancing treatments for neurological and genetic disorders, leveraging its expertise in gene delivery systems and therapeutic development. Avigen's research is aimed at addressing unmet medical needs through cutting-edge technologies, contributing to the evolving landscape of gene-based medicine. Its commitment to scientific excellence positions it as a key player in the biotechnology sector.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

31 Patents

#14 in Alameda, CA

#2,614 in California

#10,936 in US

#21,284 in the World

Alameda, CA, United States of America

Avigen, Inc.

Forward Citations = 1,070

30 inventors:

Peter C Colosi (14 out of 21 patents)

Gary J Kurtzman (12 out of 20 patents)

Gregory M Podsakoff (5 out of 12 patents)

4. Georges Natsoulis (4 out of 5 patents)

5. Paul D Kessler (3 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Avigen, Inc.. Retrieved from https://idiyas.com/company/avigen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…